HK1137184A1 - Bis-sulfhydryl macrocyclization systems - Google Patents
Bis-sulfhydryl macrocyclization systemsInfo
- Publication number
- HK1137184A1 HK1137184A1 HK10104096.3A HK10104096A HK1137184A1 HK 1137184 A1 HK1137184 A1 HK 1137184A1 HK 10104096 A HK10104096 A HK 10104096A HK 1137184 A1 HK1137184 A1 HK 1137184A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- macrocyclization
- sulfhydryl
- bis
- systems
- sulfhydryl macrocyclization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87481906P | 2006-12-14 | 2006-12-14 | |
PCT/US2007/087615 WO2008076904A1 (en) | 2006-12-14 | 2007-12-14 | Bis-sulfhydryl macrocyclization systems |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137184A1 true HK1137184A1 (en) | 2010-07-23 |
Family
ID=39536693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10104096.3A HK1137184A1 (en) | 2006-12-14 | 2010-04-27 | Bis-sulfhydryl macrocyclization systems |
Country Status (10)
Country | Link |
---|---|
US (5) | US7960506B2 (xx) |
EP (2) | EP2094721B1 (xx) |
JP (3) | JP5656407B2 (xx) |
CN (2) | CN105061577A (xx) |
AU (1) | AU2007333846B2 (xx) |
BR (1) | BRPI0720306A2 (xx) |
CA (1) | CA2686827C (xx) |
HK (1) | HK1137184A1 (xx) |
IL (1) | IL199301A (xx) |
WO (1) | WO2008076904A1 (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348571A (zh) * | 2015-09-03 | 2018-07-31 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
PT1680443E (pt) | 2003-11-05 | 2013-12-11 | Harvard College | Péptidos alfa-helicoidais estabilizados e suas utilizações |
US7202332B2 (en) * | 2004-05-27 | 2007-04-10 | New York University | Methods for preparing internally constrained peptides and peptidomimetics |
CA2669696A1 (en) | 2006-11-15 | 2008-05-22 | Dana-Farber Cancer Institute, Inc. | Stabilized maml peptides and uses thereof |
US7981998B2 (en) * | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
WO2008076904A1 (en) | 2006-12-14 | 2008-06-26 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
AU2008210434C8 (en) | 2007-01-31 | 2014-03-27 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
WO2008104000A2 (en) | 2007-02-23 | 2008-08-28 | Aileron Therapeutics, Inc. | Triazole macrocycle systems |
BRPI0809366B8 (pt) * | 2007-03-28 | 2021-05-25 | Harvard College | polipeptídeo substancialmente alfa-helicoidal, método para fabricação do mesmo, aminoácido e composição farmacêutica |
AU2008247606A1 (en) * | 2007-05-02 | 2008-11-13 | Dana-Farber Cancer Institute, Inc. | Methods of modulating cellular homeostatic pathways and cellular survival |
JP5653219B2 (ja) * | 2007-12-31 | 2015-01-14 | ニューヨーク ユニバーシティ | 水素結合サロゲートをベースとする人工ヘリックスによるウイルス宿主膜融合の制御 |
CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
US20110144303A1 (en) * | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
WO2009126292A2 (en) * | 2008-04-08 | 2009-10-15 | Aileron Therapeutics, Inc. | Biologically active peptidomimetic macrocycles |
EP2285970A4 (en) * | 2008-06-03 | 2011-10-12 | Aileron Therapeutics Inc | COMPOSITIONS AND METHODS FOR REINFORCING THE CELL TRANSPORT OF BIOMOLECULES |
EP2356139A4 (en) | 2008-07-23 | 2013-01-09 | Harvard College | LIGATURE OF STAPLED POLYPEPTIDES |
WO2010033617A2 (en) | 2008-09-16 | 2010-03-25 | The Research Foundation Of State University Of New York | Stapled peptides and method of synthesis |
EP2342222B1 (en) * | 2008-09-22 | 2018-03-21 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP2342221B1 (en) | 2008-09-22 | 2018-11-07 | Aileron Therapeutics, Inc. | Methods for preparing purified polypeptide compositions |
CA2737918A1 (en) * | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP2012503024A (ja) * | 2008-09-22 | 2012-02-02 | エルロン・セラピューティクス・インコーポレイテッド | ペプチド模倣大環状分子 |
WO2010034026A1 (en) * | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CA2737920A1 (en) * | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CA2743177A1 (en) * | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
WO2010083347A2 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP5663498B2 (ja) * | 2009-02-27 | 2015-02-04 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドMimetogen Pharmaceuticals, Inc. | 網膜色素変性症を処置するためのペプチド模倣環状化合物 |
AU2010273220B2 (en) | 2009-07-13 | 2015-10-15 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
AU2010306718A1 (en) * | 2009-10-14 | 2012-05-24 | Aileron Therapeutics, Inc. | Improved peptidomimetic macrocycles |
US8859723B2 (en) | 2010-08-13 | 2014-10-14 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
AU2011325910B2 (en) | 2010-11-12 | 2016-03-24 | Dana Farber Cancer Institute, Inc. | Cancer therapies and diagnostics |
EP2651964B1 (en) | 2010-12-15 | 2018-02-28 | The Research Foundation of State University of New York | Cross-linked peptides and proteins, methods of making same, and uses thereof |
CN103347532A (zh) * | 2011-02-04 | 2013-10-09 | 爱奇司治疗公司 | 口服可生物利用肽药物组合物及其方法 |
WO2012174423A1 (en) | 2011-06-17 | 2012-12-20 | President And Fellows Of Harvard College | Stabilized polypeptides as regulators of rab gtpase function |
CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
US8927500B2 (en) * | 2012-02-15 | 2015-01-06 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US8987414B2 (en) | 2012-02-15 | 2015-03-24 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
WO2013126703A1 (en) * | 2012-02-22 | 2013-08-29 | New York University | Reversibly crosslinked helical hydrogen bond surrogate macrocycles |
WO2013173755A1 (en) | 2012-05-18 | 2013-11-21 | The Regents Of The University Of California | Modification of peptides using a bis(thioether)arylbridge approach |
HUE054444T2 (hu) | 2012-09-26 | 2021-09-28 | Harvard College | Prolinnal lezárt kapcsos peptidek és felhasználásuk |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
KR20150131244A (ko) | 2013-03-13 | 2015-11-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스테이플드 및 스티치드 폴리펩티드 및 그의 용도 |
DK2976325T3 (en) | 2013-03-21 | 2017-06-06 | Sanofi Aventis Deutschland | SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID |
US10087221B2 (en) | 2013-03-21 | 2018-10-02 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
CN105492460A (zh) | 2013-06-14 | 2016-04-13 | 哈佛大学的校长及成员们 | 稳定化多肽胰岛素受体调控剂 |
WO2015038938A1 (en) | 2013-09-13 | 2015-03-19 | The California Institute For Biomedical Research | Modified therapeutic agents and compositions thereof |
CN105764522A (zh) * | 2013-10-28 | 2016-07-13 | 诺雷克斯股份有限公司 | Nmda受体调节剂及其前药、盐和用途 |
EP4212180A1 (en) | 2013-12-18 | 2023-07-19 | The Scripps Research Institute | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof |
WO2015153761A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Rochester | Macrocyclic peptidomimetics for alpha-helix mimicry |
CN106573032B (zh) | 2014-05-21 | 2022-03-18 | 哈佛大学的校长及成员们 | Ras抑制肽和其用途 |
US10905739B2 (en) | 2014-09-24 | 2021-02-02 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
SG10201902594QA (en) * | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
MX2017011834A (es) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
US11155577B2 (en) | 2015-06-22 | 2021-10-26 | University Of Utah Research Foundation | Thiol-ene based peptide stapling and uses thereof |
WO2017004548A1 (en) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP3347372A4 (en) | 2015-09-10 | 2019-09-04 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 |
US11034720B2 (en) | 2016-07-17 | 2021-06-15 | University Of Utah Research Foundation | Thiol-yne based peptide stapling and uses thereof |
WO2020023502A1 (en) | 2018-07-23 | 2020-01-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
US11345725B2 (en) | 2019-09-16 | 2022-05-31 | Research Foundation Of The City University Of New York | Bis-thioether stapled peptides as inhibitors of PRC2 function |
Family Cites Families (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000259A (en) * | 1975-06-16 | 1976-12-28 | American Home Products Corporation | Cyclic dodecapeptide analogs of somatostatin and intermediates |
US4438270A (en) | 1977-07-11 | 1984-03-20 | Merrell Toraude Et Compagnie | α-Halomethyl derivatives of α-amino acids |
US4191754A (en) * | 1979-02-28 | 1980-03-04 | Merck & Co., Inc. | Bicyclic somatostatin analogs |
AU3439589A (en) | 1988-03-24 | 1989-10-16 | Terrapin Diagnostics, Inc. | Molecular sticks for controlling protein conformation |
US5650133A (en) * | 1990-01-19 | 1997-07-22 | Nycomed Salutar | Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality |
CA2047042A1 (en) | 1990-07-19 | 1992-01-20 | John Hannah | Cyclic hiv principal neutralizing determinant peptides |
AU1570292A (en) | 1991-02-07 | 1992-09-07 | Board Of Trustees Of The University Of Illinois, The | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
CA2084061A1 (en) | 1991-04-09 | 1992-10-10 | Arthur M. Felix | Growth hormone releasing factor analogs |
US5364851A (en) * | 1991-06-14 | 1994-11-15 | International Synthecon, Llc | Conformationally restricted biologically active peptides, methods for their production and uses thereof |
GB9114949D0 (en) | 1991-07-11 | 1991-08-28 | Smithkline Beecham Plc | Novel compounds |
US5411860A (en) * | 1992-04-07 | 1995-05-02 | The Johns Hopkins University | Amplification of human MDM2 gene in human tumors |
AU6770794A (en) | 1993-04-23 | 1994-11-21 | Herbert J. Evans | Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
US5446128A (en) * | 1993-06-18 | 1995-08-29 | The Board Of Trustees Of The University Of Illinois | Alpha-helix mimetics and methods relating thereto |
US5622852A (en) * | 1994-10-31 | 1997-04-22 | Washington University | Bcl-x/Bcl-2 associated cell death regulator |
US6287787B1 (en) | 1993-11-24 | 2001-09-11 | Torrey Pines Institute For Molecular Studies | Dimeric oligopeptide mixture sets |
US5824483A (en) * | 1994-05-18 | 1998-10-20 | Pence Inc. | Conformationally-restricted combinatiorial library composition and method |
US5770377A (en) * | 1994-07-20 | 1998-06-23 | University Of Dundee | Interruption of binding of MDM2 and P53 protein and therapeutic application thereof |
US6169073B1 (en) * | 1995-02-16 | 2001-01-02 | Bayer Corporation | Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
US5675001A (en) | 1995-03-14 | 1997-10-07 | Hoffman/Barrett, L.L.C. | Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom |
JP3599346B2 (ja) | 1995-05-04 | 2004-12-08 | ザ スクリップス リサーチ インスティチュート | 天然型化学連結反応によるタンパク質の合成 |
US5811515A (en) * | 1995-06-12 | 1998-09-22 | California Institute Of Technology | Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis |
US5840833A (en) * | 1995-10-27 | 1998-11-24 | Molecumetics, Ltd | Alpha-helix mimetics and methods relating thereto |
US5849954A (en) | 1996-01-18 | 1998-12-15 | Research Corporation Technologies, Inc. | Method of peptide synthesis |
US5849691A (en) * | 1996-02-20 | 1998-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II |
US5817752A (en) * | 1996-06-06 | 1998-10-06 | La Jolla Pharmaceutical Company | Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
US5663316A (en) * | 1996-06-18 | 1997-09-02 | Clontech Laboratories, Inc. | BBC6 gene for regulation of cell death |
US7083983B2 (en) * | 1996-07-05 | 2006-08-01 | Cancer Research Campaign Technology Limited | Inhibitors of the interaction between P53 and MDM2 |
US5955593A (en) * | 1996-09-09 | 1999-09-21 | Washington University | BH3 interacting domain death agonist |
US5965703A (en) * | 1996-09-20 | 1999-10-12 | Idun Pharmaceuticals | Human bad polypeptides, encoding nucleic acids and methods of use |
US5856445A (en) * | 1996-10-18 | 1999-01-05 | Washington University | Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator |
US6271198B1 (en) * | 1996-11-06 | 2001-08-07 | Genentech, Inc. | Constrained helical peptides and methods of making same |
US5955893A (en) * | 1996-12-16 | 1999-09-21 | Macronix International Co., Ltd. | Power saving buffer circuit buffer bias voltages |
EP1015479A4 (en) | 1997-04-11 | 2002-07-24 | Lilly Co Eli | COMBINATIVE SUBSTANCE LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND THE RELATED METHODS |
CA2289960A1 (en) | 1997-05-15 | 1998-11-19 | Kyowa Hakko Kogyo Co., Ltd. | Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein |
WO1999014321A1 (en) * | 1997-09-17 | 1999-03-25 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
US6326354B1 (en) * | 1998-08-19 | 2001-12-04 | Washington University | Modulation of apoptosis with bid |
EP1216309A2 (en) | 1999-03-01 | 2002-06-26 | Variagenics, Inc. | Methods for targeting rna molecules |
KR100558131B1 (ko) * | 1999-03-29 | 2006-03-10 | 더 프록터 앤드 갬블 캄파니 | 멜라노코르틴 수용체 리간드를 함유하는 약제학적 조성물및 멜라노코르틴 수용체 리간드를 함유하는 약제의제조방법 |
US6713280B1 (en) * | 1999-04-07 | 2004-03-30 | Thomas Jefferson University | Enhancement of peptide cellular uptake |
US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
DE10009341A1 (de) | 2000-02-22 | 2001-09-06 | Florian Kern | Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten |
AU2001284942A1 (en) * | 2000-08-16 | 2002-02-25 | Georgetown University Medical Center | Small molecule inhibitors targeted at bcl-2 |
US20050054770A1 (en) | 2001-03-09 | 2005-03-10 | Spatola Arno F. | Helicomimetics and stabilized lxxll peptidomimetics |
US20040106548A1 (en) * | 2001-09-07 | 2004-06-03 | Schmidt Michelle A | Conformationally constrained labeled peptides for imaging and therapy |
WO2003057158A2 (en) * | 2001-12-31 | 2003-07-17 | Dana-Farber Cancer Institute, Inc. | Method of treating apoptosis and compositions thereof |
IL162604A0 (en) | 2002-01-03 | 2005-11-20 | Yissum Res Dev Co | Conformationally constrained c-backbone cyclic peptides |
WO2003070892A2 (en) | 2002-02-15 | 2003-08-28 | The Regents Of The University Of Michigan | Inhibitors of rgs proteins |
US20030166138A1 (en) * | 2002-02-21 | 2003-09-04 | Todd Kinsella | Cyclic peptides and analogs useful to treat allergies |
EP2226316B1 (en) * | 2002-05-30 | 2016-01-13 | The Scripps Research Institute | Copper-catalysed ligation of azides and acetylenes |
EP1541692A1 (en) * | 2002-09-06 | 2005-06-15 | Kaneka Corporation | PROCESS FOR PRODUCING L-a-METHYLCYSTEINE DERIVATIVE |
EP1590363A4 (en) * | 2002-09-09 | 2006-11-02 | Dana Farber Cancer Inst Inc | BH3-PEPTIDES AND METHOD FOR THEIR USE |
AU2003277891A1 (en) | 2002-09-23 | 2004-04-08 | Medivir Ab | Hcv ns-3 serine protease inhibitors |
ES2336911T3 (es) * | 2002-11-07 | 2010-04-19 | Kosan Biosciences, Inc. | Trans-9,10-dehidroepotilonas c y d, sus analogos y procedimientos de preparacion. |
WO2004058804A1 (en) | 2002-12-24 | 2004-07-15 | Walter And Eliza Hall Institute Of Medical Research | Peptides and therapeutic uses thereof |
EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
AU2003902743A0 (en) * | 2003-06-02 | 2003-06-19 | Promics Pty Limited | Process for the preparation of cyclic peptides |
WO2005007675A2 (en) | 2003-07-09 | 2005-01-27 | The Scripps Research Institute | TRIAZOLE ϵ-AMINO ACIDS |
GB0317815D0 (en) | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
EP1673078B1 (en) | 2003-10-03 | 2008-05-28 | Merck & Co., Inc. | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
JP2007537989A (ja) | 2003-10-16 | 2007-12-27 | アプラーゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 安定化ペプチド |
PT1680443E (pt) * | 2003-11-05 | 2013-12-11 | Harvard College | Péptidos alfa-helicoidais estabilizados e suas utilizações |
EP1737884B1 (en) | 2004-03-19 | 2016-10-19 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
US7202332B2 (en) | 2004-05-27 | 2007-04-10 | New York University | Methods for preparing internally constrained peptides and peptidomimetics |
EP1602663A1 (en) | 2004-06-04 | 2005-12-07 | Chiralix B.V. | Triazole-linked glycoamino acids and glycopeptides |
CN100335467C (zh) | 2004-06-04 | 2007-09-05 | 中国科学院上海有机化学研究所 | 一锅法区域选择性合成5-碘代-1,4-二取代-1,2,3-三氮唑化合物 |
DE602005014804D1 (de) * | 2004-10-29 | 2009-07-16 | Schering Corp | Substituierte 5-carboxyamidpyrazoles und ä1,2,4ütriazole als viruzide |
DK1844337T3 (da) | 2005-01-24 | 2013-09-30 | Pepscan Systems Bv | Bindingsforbindelser, immunogene forbindelser og peptidmimetika |
US20070020620A1 (en) | 2005-07-14 | 2007-01-25 | Finn M G | Compositions and methods for coupling a plurality of compounds to a scaffold |
NZ574423A (en) | 2006-07-26 | 2012-04-27 | Pepscan Systems Bv | Immunogenic compounds and protein mimics |
US20080213175A1 (en) * | 2006-09-15 | 2008-09-04 | Kolb Hartmuth C | Click chemistry-derived cyclic peptidomimetics as integrin markers |
CA2669696A1 (en) * | 2006-11-15 | 2008-05-22 | Dana-Farber Cancer Institute, Inc. | Stabilized maml peptides and uses thereof |
US7981998B2 (en) * | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
WO2008076904A1 (en) | 2006-12-14 | 2008-06-26 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
EP2121007A1 (en) | 2006-12-21 | 2009-11-25 | Cytos Biotechnology AG | Circular ccr5 peptide conjugates and uses thereof |
AU2008210434C8 (en) | 2007-01-31 | 2014-03-27 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
WO2008104000A2 (en) | 2007-02-23 | 2008-08-28 | Aileron Therapeutics, Inc. | Triazole macrocycle systems |
BRPI0809366B8 (pt) | 2007-03-28 | 2021-05-25 | Harvard College | polipeptídeo substancialmente alfa-helicoidal, método para fabricação do mesmo, aminoácido e composição farmacêutica |
AU2008247606A1 (en) | 2007-05-02 | 2008-11-13 | Dana-Farber Cancer Institute, Inc. | Methods of modulating cellular homeostatic pathways and cellular survival |
JP5653219B2 (ja) | 2007-12-31 | 2015-01-14 | ニューヨーク ユニバーシティ | 水素結合サロゲートをベースとする人工ヘリックスによるウイルス宿主膜融合の制御 |
PT2235064E (pt) | 2008-01-07 | 2016-03-01 | Amgen Inc | Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática |
CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
US20110144303A1 (en) | 2008-04-08 | 2011-06-16 | Aileron Therapeutics, Inc. | Biologically Active Peptidomimetic Macrocycles |
WO2009126292A2 (en) | 2008-04-08 | 2009-10-15 | Aileron Therapeutics, Inc. | Biologically active peptidomimetic macrocycles |
EP2285970A4 (en) | 2008-06-03 | 2011-10-12 | Aileron Therapeutics Inc | COMPOSITIONS AND METHODS FOR REINFORCING THE CELL TRANSPORT OF BIOMOLECULES |
EP2356139A4 (en) | 2008-07-23 | 2013-01-09 | Harvard College | LIGATURE OF STAPLED POLYPEPTIDES |
JP2012503013A (ja) | 2008-09-18 | 2012-02-02 | ニューヨーク ユニバーシティ | HIF−1αと水素結合代替ヘリックスを有するp300/CBPの間の相互作用の阻害 |
CA2737920A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP2342221B1 (en) * | 2008-09-22 | 2018-11-07 | Aileron Therapeutics, Inc. | Methods for preparing purified polypeptide compositions |
WO2010034026A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP2012503024A (ja) | 2008-09-22 | 2012-02-02 | エルロン・セラピューティクス・インコーポレイテッド | ペプチド模倣大環状分子 |
CA2737918A1 (en) | 2008-09-22 | 2010-03-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP2342222B1 (en) | 2008-09-22 | 2018-03-21 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CA2743177A1 (en) * | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
WO2010083347A2 (en) | 2009-01-14 | 2010-07-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
AU2010273220B2 (en) | 2009-07-13 | 2015-10-15 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
AU2010306718A1 (en) | 2009-10-14 | 2012-05-24 | Aileron Therapeutics, Inc. | Improved peptidomimetic macrocycles |
US8859723B2 (en) | 2010-08-13 | 2014-10-14 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US8987412B2 (en) | 2011-03-04 | 2015-03-24 | New York University | Hydrogen bond surrogate macrocycles as modulators of Ras |
WO2012173846A2 (en) | 2011-06-06 | 2012-12-20 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US20130123196A1 (en) | 2011-08-31 | 2013-05-16 | New York University | Thioether-, ether-, and alkylamine-linked hydrogen bond surrogate peptidomimetics |
WO2013059530A2 (en) | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
US8987414B2 (en) | 2012-02-15 | 2015-03-24 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
US8927500B2 (en) | 2012-02-15 | 2015-01-06 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
US20170037086A1 (en) | 2014-04-09 | 2017-02-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with pth activity |
US10905739B2 (en) | 2014-09-24 | 2021-02-02 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
MX2017011834A (es) | 2015-03-20 | 2018-04-11 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos y usos de los mismos. |
WO2017004548A1 (en) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN108026146A (zh) | 2015-07-02 | 2018-05-11 | 达纳-法伯癌症研究所股份有限公司 | 稳定的抗微生物肽 |
US20170037105A1 (en) | 2015-08-03 | 2017-02-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
MX2018002723A (es) | 2015-09-03 | 2018-08-15 | Aileron Therapeutics Inc | Macrociclicos peptidomimeticos y usos de los mismos. |
EP3347372A4 (en) | 2015-09-10 | 2019-09-04 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 |
KR20180128022A (ko) | 2016-03-21 | 2018-11-30 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드 모방 거대고리에 대한 동반 진단 도구 |
WO2017205786A1 (en) | 2016-05-27 | 2017-11-30 | Aileron Therapeutics, Inc. | Cell permeable peptidomimetic macrocycles |
WO2017218949A2 (en) | 2016-06-17 | 2017-12-21 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
-
2007
- 2007-12-14 WO PCT/US2007/087615 patent/WO2008076904A1/en active Application Filing
- 2007-12-14 CN CN201510441012.2A patent/CN105061577A/zh active Pending
- 2007-12-14 CN CN200780050407.3A patent/CN101636407B/zh not_active Expired - Fee Related
- 2007-12-14 BR BRPI0720306-3A patent/BRPI0720306A2/pt not_active Application Discontinuation
- 2007-12-14 AU AU2007333846A patent/AU2007333846B2/en not_active Ceased
- 2007-12-14 US US11/957,325 patent/US7960506B2/en not_active Expired - Fee Related
- 2007-12-14 JP JP2009541617A patent/JP5656407B2/ja not_active Expired - Fee Related
- 2007-12-14 EP EP07869296.9A patent/EP2094721B1/en not_active Not-in-force
- 2007-12-14 CA CA2686827A patent/CA2686827C/en not_active Expired - Fee Related
- 2007-12-14 EP EP16190185.5A patent/EP3170835A1/en not_active Withdrawn
-
2009
- 2009-06-11 IL IL199301A patent/IL199301A/en active IP Right Grant
-
2010
- 2010-01-19 US US12/690,076 patent/US8609809B2/en active Active
- 2010-04-27 HK HK10104096.3A patent/HK1137184A1/xx not_active IP Right Cessation
-
2013
- 2013-11-01 US US14/070,367 patent/US9175056B2/en not_active Expired - Fee Related
-
2014
- 2014-08-08 JP JP2014163070A patent/JP5931975B2/ja not_active Expired - Fee Related
-
2015
- 2015-09-11 US US14/852,368 patent/US9675661B2/en active Active
-
2016
- 2016-04-27 JP JP2016089950A patent/JP6259861B2/ja not_active Expired - Fee Related
-
2017
- 2017-05-11 US US15/592,517 patent/US10328117B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348571A (zh) * | 2015-09-03 | 2018-07-31 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
US20170296620A1 (en) | 2017-10-19 |
CN101636407A (zh) | 2010-01-27 |
US9175056B2 (en) | 2015-11-03 |
CN105061577A (zh) | 2015-11-18 |
US20090047711A1 (en) | 2009-02-19 |
AU2007333846B2 (en) | 2014-01-23 |
JP5656407B2 (ja) | 2015-01-21 |
CA2686827A1 (en) | 2008-06-26 |
EP2094721B1 (en) | 2018-02-14 |
US9675661B2 (en) | 2017-06-13 |
JP6259861B2 (ja) | 2018-01-10 |
EP2094721A1 (en) | 2009-09-02 |
CN101636407B (zh) | 2015-08-26 |
US20140135473A1 (en) | 2014-05-15 |
US20160095896A1 (en) | 2016-04-07 |
JP5931975B2 (ja) | 2016-06-08 |
US8609809B2 (en) | 2013-12-17 |
JP2010513314A (ja) | 2010-04-30 |
WO2008076904A9 (en) | 2017-04-27 |
AU2007333846A1 (en) | 2008-06-26 |
CA2686827C (en) | 2014-09-16 |
IL199301A (en) | 2014-09-30 |
US20100184628A1 (en) | 2010-07-22 |
JP2016199546A (ja) | 2016-12-01 |
WO2008076904A1 (en) | 2008-06-26 |
EP3170835A1 (en) | 2017-05-24 |
US7960506B2 (en) | 2011-06-14 |
JP2014231516A (ja) | 2014-12-11 |
EP2094721A4 (en) | 2011-01-19 |
BRPI0720306A2 (pt) | 2014-02-04 |
US10328117B2 (en) | 2019-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137184A1 (en) | Bis-sulfhydryl macrocyclization systems | |
IL217452A0 (en) | Distributed jammer system | |
EP2043427A4 (en) | AQUAPONIC SYSTEM | |
EP2051924A4 (en) | ELEVATOR SYSTEM | |
ZA200902994B (en) | Desalination system | |
EP2069593A4 (en) | NUANCIERUNGSSYSTEME | |
GB2441224B (en) | Dust-extracting system | |
GB0614332D0 (en) | System | |
GB2424712B (en) | Fluid-gauging systems | |
GB0602276D0 (en) | System | |
GB0725049D0 (en) | Communiactions systems | |
GB0620302D0 (en) | Hugslock system | |
TWI350972B (en) | Communicating system | |
GB0621015D0 (en) | Seismography system | |
GB0614336D0 (en) | System | |
GB0620485D0 (en) | Postal systems | |
EP2134654A4 (en) | DESSALING SYSTEM | |
ZA200902958B (en) | Retainer system | |
IL178840A0 (en) | System | |
GB0614335D0 (en) | System | |
GB0607805D0 (en) | Fluxion system | |
ZA200708752B (en) | Component | |
GB0603936D0 (en) | Cleaning systems | |
ZA200607507B (en) | Operating system | |
GB0622348D0 (en) | Retaining means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211211 |